leucine has been researched along with Anterior Choroidal Artery Infarction in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ahnstedt, H; Choi, HA; Colpo, GD; Gusdon, A; Hinds, S; Kim, E; McBride, DW; McCullough, L; Pan, S; Park, E; Paz, A; Savarraj, JPJ; Xuefang, R; Zhao, Z | 1 |
Chen, M; Han, M; Meng, X; Wang, S; Wang, Z; Wu, R; Yang, Y; Zhang, J; Zhang, Y; Zhao, Q | 1 |
Bennion, DM; Donnangelo, LL; Haltigan, EA; Irwin, AJ; Pioquinto, DJ; Purich, DL; Regenhardt, RW; Sumners, C | 1 |
Fujioka, T; Hamano, R; Kanmatsuse, K; Matsumoto, K; Matsumoto, T; Mori, M; Shimazaki, E; Soma, M; Takahashi, Y; Tsunemi, A; Ueno, T; Watanabe, H | 1 |
Akar, N; Deda, G; Dönmez, B | 1 |
Alp, MS; Aspey, BS; Harrison, MJ; Patel, Y | 1 |
1 review(s) available for leucine and Anterior Choroidal Artery Infarction
Article | Year |
---|---|
Effects of combined glutamate and platelet-activating factor inhibition on the outcome of focal cerebral ischaemia - an initial screening study.
Topics: Animals; Brain Ischemia; Cerebral Infarction; Drug Combinations; Glutamic Acid; Leucine; Male; Movement Disorders; Neuroprotective Agents; Periaqueductal Gray; Piperazines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sodium Channel Blockers; Time Factors | 1997 |
5 other study(ies) available for leucine and Anterior Choroidal Artery Infarction
Article | Year |
---|---|
Leucine-Rich Alpha-2-Glycoprotein 1 is a Systemic Biomarker of Early Brain Injury and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.
Topics: Biomarkers; Brain Injuries; Brain Ischemia; Cerebral Infarction; Glycoproteins; Humans; Leucine; Subarachnoid Hemorrhage | 2023 |
Study on the anti-mitochondrial apoptosis mechanism of Erigeron breviscapus injection based on UPLC-Q-TOF-MS metabolomics and molecular docking in rats with cerebral ischemia-reperfusion injury.
Topics: Animals; Biomarkers; Brain Ischemia; Cerebral Infarction; China; Chromatography, High Pressure Liquid; Erigeron; Ischemic Stroke; Leucine; Metabolomics; Molecular Docking Simulation; Proline; Rats; Reperfusion Injury; Tandem Mass Spectrometry | 2024 |
Activation of the Neuroprotective Angiotensin-Converting Enzyme 2 in Rat Ischemic Stroke.
Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cerebral Cortex; Cerebral Infarction; Cerebrovascular Circulation; Corpus Striatum; Diminazene; Disease Models, Animal; Endothelin-1; Enzyme Activation; Imidazoles; Infarction, Middle Cerebral Artery; Infusions, Intraventricular; Leucine; Male; Neuroprotective Agents; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Renin-Angiotensin System; RNA, Messenger | 2015 |
Paraoxonase1 polymorphism Leu-Met55 is associated with cerebral infarction in Japanese population.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Aryldialkylphosphatase; Cerebral Infarction; Cholesterol; Diabetes Mellitus; Female; Genotype; Humans; Hypertension; Japan; Leucine; Lipoproteins; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; Reference Values; Triglycerides | 2003 |
FXIII gene Val34Leu polymorphism in Turkish children with cerebral infarct.
Topics: Adolescent; Cerebral Infarction; Child; Child, Preschool; DNA Mutational Analysis; Factor XIII; Female; Humans; Infant; Leucine; Male; Polymorphism, Genetic; Turkey; Valine | 2007 |